Joshua R. Disbrow - Dec 19, 2022 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Executive Officer, Director
Signature
/s/ Mark Oki as attorney-in-fact for Joshua R. Disbrow
Stock symbol
AYTU
Transactions as of
Dec 19, 2022
Transactions value $
$25,047
Form type
4
Date filed
12/21/2022, 08:17 AM
Previous filing
Nov 28, 2022
Next filing
Dec 23, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Stock Purchase $25K +112K +10.04% $0.22 1.23M Dec 19, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.213 to $0.23, inclusive. The reporting person undertakes to provide to AYTU Biopharma, Inc., any security holder of AYTU Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

Exhibit 24.1 Power of Attorney